Between one quarter and one half of older women develop symptoms and complications of urogenital aging that interfere with their day-to-day activities, functioning, or quality of life. Previous research on urogenital aging in women has focused almost exclusively on the role of postmenopausal estrogen deficiency in the development of tissue-specific markers of urogenital atrophy. Nevertheless, variations in serum estrogen levels or tissue markers of estrogen depletion do not adequately explain differences in the severity of women's urogenital symptoms, their impact on quality of life, or their responsiveness to treatment. There is a need for a multidimensional model of urogenital aging that takes into account how postmenopausal changes in estrogenicity interact with other important aging-related factors, such as changes in comorbid health conditions, decline in physical and mental functioning, and frailty and disability, to guide evaluation and management of urogenital aging symptoms in women. For this career development award, the candidate has incorporated multiple ancillary urogenital and geriatric measures into an observational cohort of ~2,000 ethnically-diverse, middle-aged and older women. Based on these measures, she will examine how older age, greater comorbidity, functional decline, and frailty influence the severity, quality-of-life impact, and utilization of treatments for symptoms of urogenital aging in postmenopausal women across the age spectrum. The proposed work has the potential to identify as-yet unrecognized geriatric factors that can influence urogenital function in older women and can lead to new strategies for preventing and treating urogenital aging symptoms. Additionally, this research may fundamentally shift evaluation and management of urogenital aging away from a narrow focus on estrogen repletion to a broader perspective that incorporates identification and treatment of geriatric conditions into prevention and treatment strategies for urogenital dysfunction in older women. With the support of experienced mentors in both geriatrics and women's health, the candidate will also pursue advanced training in geriatric medicine and geriatrics-based research, prospective longitudinal data collection and management techniques, and development and validation of self-report measures for use in diverse populations of older adults. Combined with the resources of the Beeson program and the rich training and collaborative environment of the University of California San Francisco, these research and training activities will allow the candidate to develop into an independent clinical investigator with an active, multidisciplinary research program focused on urogenital aging in older women, and will also position her to become a national leader of research at the interface of aging and women's health.

Public Health Relevance

With the aging of the population, older women are increasingly turning to their health care providers for help with symptoms and problems related to urogenital aging that can affect their everyday activities, functioning, and quality of life. The proposed work has the potential to identify as-yet unrecognized geriatric factors that contribute to urogenital aging and that may lead to new strategies for preventing and treating urogenital dysfunction as women age. Through this research, the candidate will pave the way for a more gerocentric approach to urogenital aging that addresses the broad spectrum of co-morbidity and functional factors with the potential to influence urogenital health and function in older women.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
1K23AG038335-01A1
Application #
8188828
Study Section
Special Emphasis Panel (ZAG1-ZIJ-6 (M2))
Program Officer
Salive, Marcel
Project Start
2011-09-01
Project End
2014-08-31
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
1
Fiscal Year
2011
Total Cost
$171,415
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Winkelman, William D; Warsi, Ann; Huang, Alison J et al. (2018) Sleep Quality and Daytime Sleepiness Among Women With Urgency Predominant Urinary Incontinence. Female Pelvic Med Reconstr Surg 24:76-81
Munaganuru, Nagambika; Van Den Eeden, Stephen K; Creasman, Jennifer et al. (2017) Urine leakage during sexual activity among ethnically diverse, community-dwelling middle-aged and older women. Am J Obstet Gynecol 217:439.e1-439.e8
Suskind, Anne M; Cawthon, Peggy M; Nakagawa, Sanae et al. (2017) Urinary Incontinence in Older Women: The Role of Body Composition and Muscle Strength: From the Health, Aging, and Body Composition Study. J Am Geriatr Soc 65:42-50
Gibson, Carolyn J; Mendes, Wendy Berry; Schembri, Michael et al. (2017) Cardiac autonomic function and hot flashes among perimenopausal and postmenopausal women. Menopause 24:756-761
Winkelman, William D; Huang, Alison J; Schembri, Michael et al. (2017) Modifiers of Response to Treatment With Fesoterodine for Urgency-Predominant Urinary Incontinence in a Randomized Controlled Trial. Female Pelvic Med Reconstr Surg 23:151-156
Duralde, Erin R; Walter, Louise C; Van Den Eeden, Stephen K et al. (2016) Bridging the gap: determinants of undiagnosed or untreated urinary incontinence in women. Am J Obstet Gynecol 214:266.e1-266.e9
Hunter, Mary M; Nakagawa, Sanae; Van Den Eeden, Stephen K et al. (2016) Predictors of impact of vaginal symptoms in postmenopausal women. Menopause 23:40-6
Huang, Alison J; Cummings, Steven R; Schembri, Michael et al. (2016) Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial. Menopause 23:330-4
Hsu, Amy; Nakagawa, Sanae; Walter, Louise C et al. (2015) The burden of nocturia among middle-aged and older women. Obstet Gynecol 125:35-43
Huang, Alison J; Phillips, Sara; Schembri, Michael et al. (2015) Device-guided slow-paced respiration for menopausal hot flushes: a randomized controlled trial. Obstet Gynecol 125:1130-8

Showing the most recent 10 out of 23 publications